High-Affinity Antibodies Designing of SARS-CoV-2 Based on Molecular Dynamics Simulations

SARS-CoV-2 has led to a global pandemic of new crown pneumonia, which has had a tremendous impact on human society. Antibody drug therapy is one of the most effective way of combating SARS-CoV-2. In order to design potential antibody drugs with high affinity, we used antibody S309 from patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Zihui, Liu, Hongtao, Zhou, Shuangyan, Xie, Zengyan, Yuan, Shuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820416/
https://www.ncbi.nlm.nih.gov/pubmed/36613923
http://dx.doi.org/10.3390/ijms24010481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820416/
https://www.ncbi.nlm.nih.gov/pubmed/36613923
http://dx.doi.org/10.3390/ijms24010481

Ejemplares similares